81 /100
CRITICAL RISK
Score updated Jul 14, 2026

VSEE — VSee Health, Inc. Dilution Risk Tracker

Track VSEE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VSEE — Get alerts when the score changes →

As of July 14, 2026, VSee Health, Inc. (VSEE) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. VSee Health, Inc. has a market capitalization of $9.21M, 48.60M shares outstanding, 13 institutional holders tracked. Key dilution vectors include shelf registration capacity of $1.00B, ATM program capacity of $6.00M, approximately 4 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
85
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
60%
💰 Capital Raise 73%
• Low cash runway: 4 months remaining
• Active shelf registration ($1000M, 10858% of market cap)
🔄 Reverse Split 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 4 months cash — financial pressure
📉 Score Deterioration 15%
• Score already CRITICAL (81/100) — events likely imminent
🔔 Track VSEE — Get forecast alerts →

💹 Market Data

Market Cap$9.21M
Shares Outstanding48.60M
Float34.50M
Cash$1.35M
Debt$1.31M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 355.4% shares (2026Q1 vs prior)
13 institutional holders · 4.65M shares
#1 ARMISTICE CAPITAL, LLC 3.50M shares
#2 GEODE CAPITAL MANAGEMENT, LLC 437.6K shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 427.4K shares
+ 10 more holders Sign up free to view →

📉 Short Interest

Short Interest1.33M
Days to Cover1.0
% of Float3.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Mar 31, 2026
424B3 ATM Jun 26, 2026
4 INSIDER TRANSACTION Jun 02, 2026
424B3 ATM Mar 05, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for VSEE Shareholders

VSee Health, Inc. (VSEE) carries a DilutionScore of 81/100, placing it in the Critical dilution risk tier — the highest category tracked by DilutionWatch. Companies at this level typically have active capital-raising programs, compressed cash runway, or a combination of dilution vectors that together represent meaningful downside risk to share count. As of July 14, 2026, this score reflects real-time data pulled directly from SEC EDGAR filings.

The most significant dilution vector for VSEE is its shelf registration capacity of $1.00B. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. VSEE has an active ATM (at-the-market) program with $6.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for VSEE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for VSEE alongside comparable critical-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations → How ATM Offerings Work →
Track VSEE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VSEE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for VSEE
📊 VSEE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VSEE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.